09:01 AM EDT, 03/15/2024 (MT Newswires) -- Health care stocks were steady premarket Friday, with the Health Care Select Sector SPDR Fund (XLV) inactive and the iShares Biotechnology ETF (IBB) up 0.1%.

Geron ( GERN ) was rallying past 77% after saying the US Food and Drug Administration's Oncologic Drugs Advisory Committee voted in favor of the benefit-to-risk profile of imetelstat. The vote was 12-2, and the target action date for the company's new drug application is June 16, Geron ( GERN ) said.